We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App





CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases

By LabMedica International staff writers
Posted on 12 Nov 2024
Print article
Image: Certest is highlighting the new VIASURE V-FLEX system at the world’s largest healthcare exhibition event (Photo courtesy of CerTest)
Image: Certest is highlighting the new VIASURE V-FLEX system at the world’s largest healthcare exhibition event (Photo courtesy of CerTest)

CerTest Biotec (Zaragoza, Spain) is ending the 2024 exhibition calendar with its participation in this year’s MEDICA. With more than 5,300 exhibitors from almost 70 different countries, MEDICA is one of the largest medical B2B exhibitions in the world. CerTest is presenting again at MEDICA this year, highlighting the different medical diagnostic technologies it has developed to over 83,000 visitors expected at the event. At MEDICA 2024, Certest is showcasing the V-Flex system that is part of its VIASURE Complete Solution designed to achieve a better molecular diagnostic workflow. The VIASURE V-FLEX system is a new fully automated solution in molecular biology for nucleic acid extraction, purification, and PCR set-up from biological matrix and samples. The instrument has been designed with flexible configurations to meet different user needs.

Visitors to the Certest booth can also learn about the VIASURE DNA/RNA pathogen extraction kit designed to extract from various biological samples: swabs, saliva, sputum, bronchoalveolar lavages, fecal and urine samples. The kit is based on magnetic particles, which allows its automation for high throughput analysis, reducing hands-on time and improving reproducibility. The extraction kit is currently optimized for two types of magnetic separation methods: VIASURE V-Flex and KingFisher Flex. Certest is also demonstrating the VIASURE V-Smart software that allows the analysis and interpretation of the VIASURE Real-Time PCR assays. VIASURE V-Smart facilitates the conversion of the PCR raw data into test results with minimal manual intervention.

Related Links:
CerTest Biotec

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Centromere B Assay
Centromere B Test

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.